- By Jodi Tahsler
- Posted April 12, 2023
Ambry Spotlights Rob Pilarski: Seeing Genetic Testing’s Big Picture
Ambry Genetics caught up with Robert Pilarski, MS, LGC, MSW, Director of Medical Affairs, at his home on the shore in Cape Cod. He describes the town as “his happy place,” and in learning more about his role at Ambry, it seems that his career has entered a happy place as well. Rob has been with Ambry for over two years and is often sought…
- By Jodi Tahsler
- Posted March 8, 2023
International Women’s Day: Spotlighting Cathrine Keller, MD, A Woman of Substance
Being a “woman of substance” requires a passion for benefitting the greater good. Dr. Cathrine Keller has it in abundance. “We believe the greater good is to put our patients’ health and safety at the epicenter of every decision we make.” A woman of substance seldom has a neutral position. As a leader in the fight against breast cancer,…
- By Deepti Babu, MS, CGC
- Posted April 14, 2017
Ambry Genetics and Leading Academic Researchers Collaborate to Improve Knowledge of Genetic Risk Factors for Breast Cancer
New clinical evidence collected from >65,000 women with breast cancer demonstrates 83% of positive test results are found in genes that impact clinical management Multi-gene germline genetic testing allows for efficient analysis, maximizing risk assessment while minimizing the time needed for results. This has been particularly effective…